Wedbush Securities’s Escalon Medical Corp ESMC Stock Holding History

Wedbush Securities’s Portfolio ESMC Stock Details ESMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-181,183	Closed	-$19K	–	906
2016 Q4	$19K	Hold	181,183	–	–	﹤0.01%	806
2016 Q3	$121K	Buy	181,183 +7,825	+5%	+$5.65K	0.02%	735
2016 Q2	$135K	Buy	173,358 +38,917	+29%	+$29.9K	0.02%	678
2016 Q1	$107K	Sell	134,441 -351	-0.3%	-$325	0.02%	660
2015 Q4	$143K	Buy	+134,792	New	+$147K	0.03%	618

Other funds holding ESMC

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Wedbush Securities's ESMC Position: Q1 2017 in Review

Wedbush Securities sold out of Escalon Medical Corp (ESMC) in Q1 2017, closing a stake of 181,183 shares — an estimated $19K sold.

Wedbush Securities first reported a position in ESMC in Q4 2015 and held it in 5 quarters. The position peaked at $143K in Q4 2015. 1 fund tracked by Wall St. Rank holds ESMC as of Q1 2017.

Wedbush Securities reported no remaining Escalon Medical Corp position as of Q1 2017 after selling out during the quarter.
Wedbush Securities sold 181,183 Escalon Medical Corp shares in Q1 2017, an estimated $19K.
Wedbush Securities first reported a position in Escalon Medical Corp in Q4 2015 and held it in 5 quarters.
Wedbush Securities's Escalon Medical Corp position peaked at $143K in Q4 2015.
1 fund tracked by Wall St. Rank held Escalon Medical Corp as of Q1 2017.

Based on Wedbush Securities's 13F filing for Q1 2017, filed 5 May 2017.